Dr. Boobalan Pachaiyappan
Recent Articles
Maryland Biotech Gains Regulatory Approval 12/26/2024
Gain Therapeutics Inc. (GANX:NASDAQ) recently received Australian regulatory approval to begin GT-02287 evaluation in Parkinson's disease (PD) patients.
Co. Addresses Opioid Crisis Through Novel Platforms 07/07/2023
This California biotech, developing products that prevent opioid abuse and overdose, gained coverage by an H.C. Wainwright & Co. analyst, an initiation report noted.
Due to permission requirements, not all quotes are shown.
